Thromboxane b2

Thromboxane b2 is a lipid of Fatty Acyls (FA) class. Thromboxane b2 is associated with abnormalities such as endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia and Thrombocytosis. The involved functions are known as Platelet Activation, Excretory function, Anabolism, Inflammation and mRNA Expression. Thromboxane b2 often locates in Endothelium, Hepatic and Microsomes, Liver. The associated genes with Thromboxane b2 are PTGS2 gene, prothrombin fragment 2 and CCL14 wt Allele.

Cross Reference

Introduction

To understand associated biological information of Thromboxane b2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Thromboxane b2?

Thromboxane b2 is suspected in endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia, Thrombocytosis, Acute Coronary Syndrome and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Thromboxane b2

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Airway Obstruction D000402 13 associated lipids
Uremia D014511 33 associated lipids
Stomach Ulcer D013276 75 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Hypoxia D000860 23 associated lipids
Graft Occlusion, Vascular D006083 11 associated lipids
Arrhythmias, Cardiac D001145 42 associated lipids
Adenocarcinoma D000230 166 associated lipids
Ovarian Neoplasms D010051 10 associated lipids
Pain D010146 64 associated lipids
Contusions D003288 3 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Lupus Erythematosus, Systemic D008180 43 associated lipids
Lung Diseases D008171 37 associated lipids
Lung Neoplasms D008175 171 associated lipids
Wounds and Injuries D014947 20 associated lipids
Pleurisy D010998 20 associated lipids
Burns D002056 34 associated lipids
Inflammation D007249 119 associated lipids
Reperfusion Injury D015427 65 associated lipids
Colitis D003092 69 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Diabetes Mellitus, Type 1 D003922 56 associated lipids
Diabetes Mellitus, Type 2 D003924 87 associated lipids
Diabetic Nephropathies D003928 39 associated lipids
Diabetic Retinopathy D003930 39 associated lipids
Cattle Diseases D002418 24 associated lipids
Fatty Liver D005234 48 associated lipids
Diabetes Mellitus, Experimental D003921 85 associated lipids
Mammary Neoplasms, Experimental D008325 67 associated lipids
Body Weight D001835 333 associated lipids
Edema D004487 152 associated lipids
Arthritis D001168 41 associated lipids
Arthritis, Experimental D001169 24 associated lipids
Hypotension D007022 41 associated lipids
Acute Kidney Injury D058186 34 associated lipids
Gastritis D005756 27 associated lipids
Heart Failure D006333 36 associated lipids
Pulmonary Edema D011654 23 associated lipids
Pulmonary Embolism D011655 5 associated lipids
Coronary Disease D003327 70 associated lipids
Liver Cirrhosis, Experimental D008106 36 associated lipids
Hypersensitivity D006967 22 associated lipids
Hypothyroidism D007037 32 associated lipids
Rhinitis D012220 10 associated lipids
Hypercapnia D006935 5 associated lipids
Arterial Occlusive Diseases D001157 12 associated lipids
Pain, Postoperative D010149 13 associated lipids
Per page 10 20 50 100 | Total 293

PubChem Associated disorders and diseases

What pathways are associated with Thromboxane b2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Thromboxane b2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Thromboxane b2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Thromboxane b2?

There are no associated biomedical information in the current reference collection.

What genes are associated with Thromboxane b2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Thromboxane b2?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Thromboxane b2

Download all related citations
Per page 10 20 50 100 | Total 6367
Authors Title Published Journal PubMed Link
Feldman M and Cryer B Aspirin absorption rates and platelet inhibition times with 325-mg buffered aspirin tablets (chewed or swallowed intact) and with buffered aspirin solution. 1999 Am. J. Cardiol. pmid:10468077
Gurbel PA et al. Plasma thromboxane and prostacyclin are linear related and increased in patients presenting with acute myocardial infarction. 1999 Prostaglandins Leukot. Essent. Fatty Acids pmid:10477035
Li D et al. The association of diet and thrombotic risk factors in healthy male vegetarians and meat-eaters. 1999 Eur J Clin Nutr pmid:10477247
Fujimoto Y et al. Sphingomyelin inhibits platelet 12-lipoxygenase activity. 1999 Eur. J. Pharmacol. pmid:10478636
Zaitsu M et al. Induction of cytosolic phospholipase A2 and prostaglandin H2 synthase-2 by lipopolysaccharide in human polymorphonuclear leukocytes. 1999 Eur. J. Haematol. pmid:10480288
Nawarskas JJ et al. Effect of aspirin on blood pressure in hypertensive patients taking enalapril or losartan. 1999 Am. J. Hypertens. pmid:10480471
Nishimaki S and Seki K An imbalance between prostacyclin and thromboxane in relation to cerebral blood flow in neonates with maternal preeclampsia. 1999 Prostaglandins Other Lipid Mediat. pmid:10482286
Obata T et al. Simultaneous assay of prostaglandins and thromboxane in the cerebrospinal fluid by gas chromatography-mass spectrometry-selected ion monitoring. 1999 J. Chromatogr. B Biomed. Sci. Appl. pmid:10491991
Fuglsang J et al. Intravenous acetylsalicylic acid, magnesium and their combination in experimental arterial thrombosis in rats. 1999 Blood Coagul. Fibrinolysis pmid:10493216
Fruzzetti F et al. Platelet-vessel wall interactions with third-generation oral contraceptives: no evidence of detrimental effects. 1999 Thromb. Haemost. pmid:10494782
Barchasz E et al. Interleukin-1beta-induced hyperresponsiveness to [Sar9,Met(O2)11]substance P in isolated human bronchi. 1999 Eur. J. Pharmacol. pmid:10499376
Tanus-Santos JE et al. Inhaled nitric oxide improves hemodynamics during a venous air infusion (VAI) in dogs. 1999 Intensive Care Med pmid:10501756
Gonchar M et al. Kinetics of prostanoid synthesis by macrophages is regulated by arachidonic acid sources. 1999 Eur. J. Biochem. pmid:10504410
Gust R et al. Role of cyclooxygenase-2 in oleic acid-induced acute lung injury. 1999 Am. J. Respir. Crit. Care Med. pmid:10508803
Thakur V et al. Antihypertensive effect of the combination of fosinopril and HCTZ is resistant to interference by nonsteroidal antiinflammatory drugs. 1999 Am. J. Hypertens. pmid:10509552
Yang SY and Gao ZX Determination and clinical significance of plasma levels of prostaglandins in patients with acute brain injury. 1999 Surg Neurol pmid:10511080
Cryer B et al. Effects of cutaneous aspirin on the human stomach and duodenum. 1999 Sep-Oct Proc. Assoc. Am. Physicians pmid:10519166
Véricel E et al. The influence of low intake of n-3 fatty acids on platelets in elderly people. 1999 Atherosclerosis pmid:10525140
Serebruany VL et al. Effects of a novel Mac-1 inhibitor, NPC 15669, on hemostatic parameters during preconditioned myocardial infarction. 1999 Life Sci. pmid:10530802
Chou TC et al. Antiplatelet effect of amlodipine: a possible mechanism through a nitric oxide-mediated process. 1999 Biochem. Pharmacol. pmid:10535758
Pearl JM et al. Effect of modified ultrafiltration on plasma thromboxane B2, leukotriene B4, and endothelin-1 in infants undergoing cardiopulmonary bypass. 1999 Ann. Thorac. Surg. pmid:10543508
de Meijer A et al. Meloxicam, 15 mg/day, spares platelet function in healthy volunteers. 1999 Clin. Pharmacol. Ther. pmid:10546927
Reeves JH et al. Continuous plasmafiltration in sepsis syndrome. Plasmafiltration in Sepsis Study Group. 1999 Crit. Care Med. pmid:10548188
Nemcova S et al. Cyclic nucleotides and production of prostanoids in human varicose veins. 1999 J. Vasc. Surg. pmid:10550185
Hirakata H et al. Propofol has both enhancing and suppressing effects on human platelet aggregation in vitro. 1999 Anesthesiology pmid:10551587
Heller A et al. Pancreatitis-associated protein protects the lung from leukocyte-induced injury. 1999 Anesthesiology pmid:10551593
Titos E et al. Hepatocytes are a rich source of novel aspirin-triggered 15-epi-lipoxin A(4). 1999 Am. J. Physiol. pmid:10564079
Castellani S et al. Impaired renal adaptation to stress in the elderly with isolated systolic hypertension. 1999 Hypertension pmid:10567190
Vijaya Kumar M et al. The anhydrous milk fat, ghee, lowers serum prostaglandins and secretion of leukotrienes by rat peritoneal macrophages. 1999 Prostaglandins Leukot. Essent. Fatty Acids pmid:10574649
Gallery ED et al. In vitro human decidual endothelial cell thromboxane secretion in preeclampsia is not abnormal. 1999 Hypertens Pregnancy pmid:10586525
Pirich C et al. Effects of fish oil supplementation on platelet survival and ex vivo platelet function in hypercholesterolemic patients. 1999 Thromb. Res. pmid:10588465
Pavord ID et al. Induced sputum eicosanoid concentrations in asthma. 1999 Am. J. Respir. Crit. Care Med. pmid:10588604
Mizugaki M et al. Monitoring of the thromboxane A2/prostacyclin ratio in the urine of patients with retinal vascular occlusion through the low-dose-aspirin therapy using the gas chromatography/selected ion monitoring method. 1999 Prostaglandins Other Lipid Mediat. pmid:10593167
Hishinuma T et al. Urinary thromboxane A2/prostacyclin balance reflects the pathological state of a diabetic. 1999 Prostaglandins Other Lipid Mediat. pmid:10593168
Hoch B and Bernhard M Reduced prostacyclin to thromboxane A2 ratio is correlated with central apneas in preterm infants. 1999 Prostaglandins Other Lipid Mediat. pmid:10593170
Kohda N et al. Effect of cilostazol, a phosphodiesterase III inhibitor, on experimental thrombosis in the porcine carotid artery. 1999 Thromb. Res. pmid:10593428
Chou TC and Li CY Inhibitory mechanisms of dantrolene on platelet aggregation. 1999 Thromb. Res. pmid:10593433
De La Cruz JP et al. Antiplatelet effect of the anaesthetic drug propofol: influence of red blood cells and leucocytes. 1999 Br. J. Pharmacol. pmid:10602334
Reis F et al. The peripheral serotonergic system and platelet aggregation in cyclosporin A-induced hypertensive rats. 1999 Thromb. Res. pmid:10605951
Eldor A et al. A chronic hypercoagulable state in patients with beta-thalassaemia major is already present in childhood. 1999 Br. J. Haematol. pmid:10606878
Ferro D et al. Determinants of enhanced thromboxane biosynthesis in patients with systemic lupus erythematosus. 1999 Arthritis Rheum. pmid:10616019
Uriu K et al. Effect of acute thromboxane A2 inhibition on the renal hemodynamics in a spontaneously non-insulin-dependent diabetic rat, Otsuka Long-Evans Tokushima Fatty rat. 1999 Jul-Aug J. Diabetes Complicat. pmid:10616856
Tanus-Santos JE et al. The hemodynamic effects of endothelin receptor antagonism during a venous air infusion in dogs. 2000 Anesth. Analg. pmid:10624986
Dahlin KL et al. Amitriptyline-induced release of endothelin-1 in isolated perfused and ventilated rat lungs. 1999 Pharmacol. Toxicol. pmid:10628905
Perneby C et al. Optimization of an enzyme immunoassay for 11-dehydro-thromboxane B(2) in urine: comparison with GC-MS. 1999 Thromb. Res. pmid:10632465
Miura M and Kurimoto F [Thromboxane B2 (TXB2)]. 1999 Nippon Rinsho pmid:10635957
González E et al. Evolution of streptozotocin-pancreatic damage in the rat: modulatory effect of endothelins on the nitridergic and prostanoid pathway. 1999 Nitric Oxide pmid:10637124
Stewart KG et al. Estrogen decreases prostaglandin H synthase products from endothelial cells. 1999 Nov-Dec J. Soc. Gynecol. Investig. pmid:10643586
Gajdos M et al. [The effect of monotherapy with ciprofibrate and in combination with acetylsalicylic acid on the spectrum of lipids, thromboxane and fibrinogen in patients with atherosclerosis and hyperlipoproteinemia]. 1999 Bratisl Lek Listy pmid:10645034
Montini G et al. Renal glomerular response to the inhibition of prostaglandin E2 synthesis and protein loading after the relief of unilateral ureteropelvic junction obstruction. 2000 J. Urol. pmid:10647684
Chou TC et al. Mechanism of inhibition of platelet aggregation by HCL-31D. 2000 Eur. J. Pharmacol. pmid:10650152
Landoni MF et al. Enantiospecific pharmacokinetics and pharmacodynamics of ketoprofen in sheep. 1999 J. Vet. Pharmacol. Ther. pmid:10651463
Hansen JM et al. Effects of nitric oxide blockade and cyclosporin A on cardiovascular and renal function in normal man. 1999 J. Hypertens. pmid:10658936
Matsumoto H and Nakao T Elevated urinary excretion of thromboxane B2 in adults with minimal-change nephrotic syndrome. 2000 Clin. Nephrol. pmid:10661487
Leese PT et al. Effects of celecoxib, a novel cyclooxygenase-2 inhibitor, on platelet function in healthy adults: a randomized, controlled trial. 2000 J Clin Pharmacol pmid:10664917
Okumura M et al. Renal production of thromboxane and prostaglandins in a rat model of type 2 diabetes. 2000 Life Sci. pmid:10670825
Wu TM et al. Inhibitory effect of hexapeptide (RGRHGD) on platelet aggregation. 2000 Thromb. Res. pmid:10674405
De La Cruz JP et al. Effect of DT-TX 30, a combined thromboxane synthase inhibitor and thromboxane receptor antagonist, on retinal vascularity in experimental diabetes mellitus. 2000 Thromb. Res. pmid:10680643
Zeng W et al. [Relationship between PGI2, TXA2 and threatened preterm]. 1998 Hua Xi Yi Ke Da Xue Xue Bao pmid:10684102
Nagano K et al. Prostanoids regulate proliferation of vascular smooth muscle cells induced by arginine vasopressin. 2000 Eur. J. Pharmacol. pmid:10686292
Tegeder I et al. Effects of selective and unselective cyclooxygenase inhibitors on prostanoid release from various rat organs. 2000 J. Pharmacol. Exp. Ther. pmid:10688636
Nosál R and Jancinová V Nonreceptor interactions in the pharmacology of blood platelets. 1999 Gen. Physiol. Biophys. pmid:10703730
Suntres ZE and Shek PN Prophylaxis against lipopolysaccharide-induced lung injuries by liposome-entrapped dexamethasone in rats. 2000 Biochem. Pharmacol. pmid:10704946
Weber AA et al. 40 mg of aspirin are not sufficient to inhibit platelet function under conditions of limited compliance. 2000 Thromb. Res. pmid:10709913
Okada S et al. Perfusion of the hypothalamic paraventricular nucleus with N-methyl-D-aspartate produces thromboxane A2 and centrally activates adrenomedullary outflow in rats. 2000 Neuroscience pmid:10717438
Zaitsu M et al. Ulinastatin, an elastase inhibitor, inhibits the increased mRNA expression of prostaglandin H2 synthase-type 2 in Kawasaki disease. 2000 J. Infect. Dis. pmid:10720537
Pärsson HN et al. Maintaining carotid flow by shunting during carotid endarterectomy diminishes the inflammatory response mediating ischaemic brain injury. 2000 Eur J Vasc Endovasc Surg pmid:10727360
Jacobi K et al. Plasma levels of eicosanoids after transfusion of intraoperatively salvaged blood. 2000 Vox Sang. pmid:10729809
Homoncik M et al. Monitoring of aspirin (ASA) pharmacodynamics with the platelet function analyzer PFA-100. 2000 Thromb. Haemost. pmid:10739392
Schweizer A et al. Aprotinin does not impair renal haemodynamics and function after cardiac surgery. 2000 Br J Anaesth pmid:10740541
Nenci GG and Paliani U [Diabetes, coagulation and vascular events]. 2000 Recenti Prog Med pmid:10748654
Bailey SR et al. Actions and interactions of ADP, 5- HT, histamine and PAF on equine platelets. 2000 Res. Vet. Sci. pmid:10756136
Liao CH et al. Antiplatelet effect of marchantinquinone, isolated from Reboulia hemisphaerica, in rabbit washed platelets. 2000 J. Pharm. Pharmacol. pmid:10757426
Prieto MA et al. Influence of triflusal on platelet activation after coronary artery bypass graft. 2000 Blood Coagul. Fibrinolysis pmid:10759013
Heller A et al. The complement regulators C1 inhibitor and soluble complement receptor 1 attenuate acute lung injury in rabbits. 2000 Shock pmid:10774617
Agnoli GC et al. Renal synthesis of prostacyclin and thromboxane in healthy women: differential effects of a short-term saline loading. 2000 Prostaglandins Leukot. Essent. Fatty Acids pmid:10780876
Jacobs C et al. 1-imidazolyl(alkyl)-substituted di- and tetrahydroquinolines and analogues: syntheses and evaluation of dual inhibitors of thromboxane A(2) synthase and aromatase. 2000 J. Med. Chem. pmid:10794700
Zhao S et al. Glioma prostaglandin levels correlate with brain edema. 1998 J. Tongji Med. Univ. pmid:10806839
Wakitani K et al. JTE-522 selectively inhibits cyclooxygenase-2-derived prostaglandin production in inflammatory tissues. 2000 Inflamm. Res. pmid:10807499
Gardan B et al. Vasoconstrictor effects of iso-prostaglandin F2alpha type-III (8-iso-prostaglandin F2alpha) on human saphenous veins. 2000 J. Cardiovasc. Pharmacol. pmid:10813374
Jacobi KE et al. Determination of eicosanoid and cytokine production in salvaged blood, stored red blood cell concentrates, and whole blood. 2000 J Clin Anesth pmid:10818321
Tanus-Santos JE et al. Endothelin ET(A) receptor antagonism attenuates the pressor effects of nicotine in rats. 2000 Eur. J. Pharmacol. pmid:10822051
Turpeinen AM et al. Similar responses in hemostatic factors after consumption of wholemeal rye bread and low-fiber wheat bread. 2000 Eur J Clin Nutr pmid:10822290
Romano M et al. Fluvastatin reduces soluble P-selectin and ICAM-1 levels in hypercholesterolemic patients: role of nitric oxide. 2000 J. Investig. Med. pmid:10822898
Sheu JR et al. Mechanisms involved in the antiplatelet activity of Staphylococcus aureus lipoteichoic acid in human platelets. 2000 Thromb. Haemost. pmid:10823277
Nosál' R et al. Chloroquine: a multipotent inhibitor of human platelets in vitro. 2000 Thromb. Res. pmid:10828481
Maccarrone M et al. Activation of different lipoxygenase isozymes induces apoptosis in human erythroleukemia and neuroblastoma cells. 2000 Biochem. Biophys. Res. Commun. pmid:10833416
Semenov AV et al. [Soluble P-selectin - a marker of platelet activation and vessel wall injury: increase of soluble P-selectin in plasma of patients with myocardial infarction, massive atherosclerosis and primary pulmonary hypertension]. 2000 Ter. Arkh. pmid:10833791
Numminen H et al. The effect of acute ingestion of a large dose of alcohol on the hemostatic system and its circadian variation. 2000 Stroke pmid:10835443
Sakamoto K et al. An imbalance in plasma prostanoids in patients with Raynaud's phenomenon and pulmonary vasospasm. 1999 Eur. Respir. J. pmid:10836338
Cracowski JL et al. Human internal mammary artery contraction by isoprostaglandin f(2alpha) type-III [8-iso-prostaglandin F(2alpha)]. 2000 Eur. J. Pharmacol. pmid:10844110
Rioja I et al. An anti-inflammatory ditriazine inhibiting leukocyte functions and expression of inducible nitric oxide synthase and cyclo-oxygenase-2. 2000 Eur. J. Pharmacol. pmid:10844115
Tran HS et al. The cardiovascular hemodynamics and leukotriene kinetics during prostacyclin and anti-prostacyclin antibody infusions in septic shock. 2000 Shock pmid:10847636
Carty E et al. Ridogrel, a dual thromboxane synthase inhibitor and receptor antagonist: anti-inflammatory profile in inflammatory bowel disease. 2000 Aliment. Pharmacol. Ther. pmid:10848666
Theriot JA et al. Dietary chloride does not correlate with urinary thromboxane in deoxycorticosterone acetate-treated rats. 2000 J. Lab. Clin. Med. pmid:10850649
Mizugaki M [Microdetermination of eicosanoids using mass spectrometry]. 2000 Nippon Yakurigaku Zasshi pmid:10876809
Depré M et al. Pharmacokinetics, COX-2 specificity, and tolerability of supratherapeutic doses of rofecoxib in humans. 2000 Eur. J. Clin. Pharmacol. pmid:10877012
Moon CH et al. Mechanism for antiplatelet effect of onion: AA release inhibition, thromboxane A(2)synthase inhibition and TXA(2)/PGH(2)receptor blockade. 2000 Prostaglandins Leukot. Essent. Fatty Acids pmid:10883058
Lasserre B et al. Modifications in the TXA(2) and PGI(2) plasma levels and some other biochemical parameters during the initiation and development of non-insulin-dependent diabetes mellitus (NIDDM) syndrome in the rabbit. 2000 Prostaglandins Leukot. Essent. Fatty Acids pmid:10883059
Bereczki C et al. The roles of platelet function, thromboxane, blood lipids and nitric oxide in hypertension of children and adolescents. 2000 Prostaglandins Leukot. Essent. Fatty Acids pmid:10883060